In a large trial, patients with positive blood tests for circulating tumor DNA (ctDNA) after surgery had worse outcomes in general. Read more: https://pharma.economictimes.indiatimes.com/news/research-and-development/old-anti-inflammatory-may-delay-colon-cancer-recurrence/117809439